as 01-14-2025 4:00pm EST
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Founded: | 2010 | Country: | United States |
Employees: | N/A | City: | BOCA RATON |
Market Cap: | 118.2M | IPO Year: | 2016 |
Target Price: | $12.50 | AVG Volume (30 days): | 244.3K |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.57 | EPS Growth: | N/A |
52 Week Low/High: | $2.61 - $9.33 | Next Earning Date: | 02-06-2025 |
Revenue: | $41,308,000 | Revenue Growth: | 65.62% |
Revenue Growth (this year): | 65.04% | Revenue Growth (next year): | 24.87% |
SRTS Breaking Stock News: Dive into SRTS Ticker-Specific Updates for Smart Investing
Zacks
7 days ago
Simply Wall St.
15 days ago
Zacks
19 days ago
Zacks
19 days ago
Zacks
a month ago
Simply Wall St.
a month ago
Zacks
a month ago
Zacks
a month ago
The information presented on this page, "SRTS Sensus Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.